Sinopharm: 2021 Equity Distribution Implementation Notice
Sinopharm: Progress announcement on the public delisting of Sinopharm Holding Guoda Pharmacy Co., Ltd. and the transfer of 100% of the shares of Chengda Fangyuan Pharmaceutical Group Co., Ltd.
Sinopharm agreed: Announcement on related transactions involving the acquisition of 100% of the shares of Shanghai Dingqun Enterprise Management Consulting Co., Ltd., by the holding subsidiary Sinopharm Holding Guoda Pharmacy Co., Ltd. and 85% of the share
Sinopharm is consistent: Announcement on asset sales, issuance of shares, payment of cash to purchase assets and raising supporting funds, and fulfillment of commitments issued by parties involved in related transactions
Sinopharm Consistent: Notice on Asset Sales, Issuance of Shares, and Transfer of Assets Subject to Cash to Purchase Assets and Raise Supporting Funds and Related Transactions
Sinopharm: Announcement of Resolutions of the First Interim Meeting of the Seventh Board of Directors in 2015
Sinopharm: Announcement of Resolutions of the 12th Meeting of the Seventh Board of Directors
Sinopharm: Announcement of Resolutions of the Sixth Meeting of the Seventh Supervisory Board
Sinopharm: Announcement of Resolutions of the Eighth Meeting of the Seventh Board of Directors
Sinopharm: Announcement of Resolutions of the 23rd Meeting of the Sixth Board of Directors
Sinopharm: Announcement of Resolutions of the 20th Meeting of the Sixth Board of Directors
Sinopharm: 2012 First Short-Term Financing Note Payment Notice
Sinopharm: Announcement of Resolutions of the 11th Meeting of the Sixth Board of Directors
Sinopharm agreed: Announcement on the acquisition of 100% of the shares of Jiangmen Renren Pharmaceutical Co., Ltd.
Unilever Pharmaceutical: Announcement on Application for Issuance of Short-Term Financing Notes
Unification Pharmaceutical: Announcement on the progress of the equity acquisition project
Tongyi Pharmaceutical: Announcement on the acquisition of the pharmaceutical business and corresponding assets and liabilities of Nanning Pharmaceutical Co., Ltd.
Unification Pharmaceutical: Announcement on the Implementation Status of Asset Acquisition and Sale
Unilever Pharmaceuticals: Supplemental Announcement on Takeover
No Data
No Data